Evidence map›Paper›PMID 15867091›Full record

ArticleThe Journal of experimental medicine2005

Differential requirement for OBF-1 during antibody-secreting cell differentiation.

Lynn M Corcoran, Jhagvaral Hasbold, Wendy Dietrich, Edwin Hawkins, Axel Kallies, Stephen L Nutt, David M Tarlinton, Patrick Matthias, Philip D Hodgkin

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. The Role of the Transcriptional Coactivator BOB.1/OBF.1 in Adaptive Immunity.Advances in experimental medicine and biology · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. High-affinity IgMScientific reports · 2018
    Article
  11. Review
  12. Article
  13. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  14. Article
  15. Article
  16. The generation of antibody-secreting plasma cells.Nature reviews. Immunology · 2015
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Lynn M CorcoranThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia. corcoran@wehi.edu.au
Jhagvaral Hasbold
Wendy Dietrich
Edwin Hawkins
Axel Kallies
Stephen L Nutt
David M Tarlinton
Patrick Matthias
Philip D Hodgkin
Walter and Eliza Hall Institute of Medical Research · AUFriedrich Miescher Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resting B cells can be cultured to induce antibody-secreting cell (ASC) differentiation in vitro. A quantitative analysis of cell behavior during such a culture allows the influences of different stimuli and gene products to be measured. The application of this analytical system revealed that the OBF-1 transcriptional coactivator, whose loss impairs antibody production in vivo, has two effects on ASC development. Although OBF-1 represses early T cell-dependent (TD) differentiation, it is also critical for the completion of the final stages of ASC development. Under these conditions, the loss of OBF-1 blocks the genetic program of ASC differentiation so that Blimp-1/prdm1 induction fails, and bcl-6, Pax5, and AID are not repressed as in control ASC. Retroviral complementation confirmed that OBF-1 was the critical entity. Surprisingly, when cells were cultured in lipopolysaccharide to mimic T cell-independent conditions, OBF-1-null B cells differentiated normally to ASC. In the OBF-1(-/-) ASC generated under either culture regimen, antibody production was normal or only modestly reduced, revealing that Ig genes are not directly dependent on OBF-1 for their expression. The differential requirement for OBF-1 in TD ASC generation was confirmed in vivo. These studies define a new regulatory role for OBF-1 in determining the cell-autonomous capacity of B cells to undergo terminal differentiation in response to different immunological signals.

Indexed as

Gene Expression RegulationAnimalsAntibody-Producing CellsCell DifferentiationCells, CulturedDNA-Binding ProteinsDNA PrimersEnzyme-Linked Immunosorbent AssayFlow CytometryGenetic Complementation TestLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutPAX5 Transcription FactorPlasma CellsDNA-Binding ProteinsDNA PrimersLipopolysaccharidesPax5 protein, mousePAX5 Transcription FactorPositive Regulatory Domain I-Binding Factor 1Pou2af1 protein, mousePrdm1 protein, mouseProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-6Repressor ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID15867091
PMCPMC2213195
OpenAlexW2135261253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.